Table of Contents
Preface
Chapter 1. Natural and Specific Inhibitors to Epithelial- Mesenchymal Transition in Cancer Stem Cells for Cancer Adjuvant Therapy
Juan Carlos Gallardo-Pérez¹, PhD, Alhelí Adán-Ladrón de Guevara², PhD, Diana Xochiquetzal Robledo-Cadena³, PhD, Cristina Trejo-Solís⁴, PhD, Erika Monserrat Navarro-Araujo⁵, MD, Irais Vilchis-Mercado⁶, Andrea Torrero-Díaz⁷, Katia Shamila García-Silva¹, Mayte Valero-Rodríguez⁶, and Samara Mendiola-Martínez⁶
¹Departamento de Fisiopatología Cardio-Renal, Instituto Nacional de Cardiología, Mexico City, Mexico
²Instituto Nacional de Cancerología, Mexico City, Mexico
³Departamento de Bioquímica, Instituto Nacional de Cardiología, Mexico City, Mexico
⁴Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico
⁵Centro Médico Nacional “20 de Noviembre,” Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico
⁶Facultad de Ciencias, UNAM, Mexico City, Mexico
⁷Universidad Simón Bolívar, Mexico City, Mexico
Chapter 2. Phosphodiesterases in Health and Diseases
Nisha Sharma and Smita Pattanaik
Department of Clinical Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Chapter 3. The Role of IL-9 and Th9 Cells in Cancer Immunity
B. Jegadeshwari and SD Saraswathy
Department of Biomedical Science, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India
Chapter 4. Combined Neuro-Vascular Modulators in the Control of Epileptic Activity
Mykhailo Pervak², PhD, Olga Yehorenko², Olesya Poshyvak³, PhD, Svitlana Liashenko¹, PhD, Oxana Onuphrienko¹, PhD, Oxana Denysenko¹, PhD, Igor Smirnov⁴, PhD, Pavlo Rozhko¹, PhD, Viktor Tselukh¹, and Kseniya Prybolovets¹
¹Department of Physiology and Biophysics Odesa National Medical University, Odesa, Ukraine
²Department of Simulative Technologies Odesa National Medical University, Odesa, Ukraine
³Department of Pharmacology, Danilo Halytsky Lviv National Medical University, Lviv, Ukraine
⁴Ukrainian Research Institute of Medical Rehabilitation and Resort Therapy, Odesa, Ukraine
Chapter 5. Subgroups Identification Using Biomarkers from Multi-Modal Brain Imaging
Yuko Ishimaru¹, MMSc, ME and Atsushi Kawaguchi², PhD
¹Clinical Research Center, Saga University Hospital, Faculty of Medicine, Saga University, Saga, Japan
²Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan
Chapter 6 Cognitive Rehabilitation and Mental Disorders
Behrooz Afshari
Department of Clinical Psychology, Kashan University of Medical Science, Kashan, Iran
Chapter 7. Prostate Benign Hyperplasia: Causes, Molecular Mechanisms, Diagnosis and Treatment
Kristina Zubow¹, Anatolij Zubow², and Viktor A. Zubow¹
¹R&D, Zubow Consulting (NPO), Peenehagen, Germany
²Group of the Telecommunication Networks Division, TU, Berlin, Germany
Chapter 8. Virus versus Cell. Model of “Struggle” for Resources
Kristina Zubow¹, Anatolij Zubow², and Viktor A. Zubow¹
¹R&D, Zubow Consulting (NPO), Peenehagen, Germany
²Group of the Telecommunication Networks Division, TU, Berlin, Germany
Chapter 9. Operative Molecular Diagnostics of Eye Muscles. Causes of Pathology and Treatment Options
Kristina Zubow¹, Anatolij Zubow², and Viktor A. Zubow¹
¹R&D, Zubow Consulting (NPO), Peenehagen, Germany
²Group of the Telecommunication Networks Division, TU, Berlin, Germany
Index

